A detailed history of Integrity Advisory, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Integrity Advisory, LLC holds 1,830 shares of ABBV stock, worth $306,067. This represents 0.29% of its overall portfolio holdings.

Number of Shares
1,830
Previous 1,853 1.24%
Holding current value
$306,067
Previous $249,000 18.47%
% of portfolio
0.29%
Previous 0.23%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 24, 2023

SELL
$138.31 - $165.87 $3,181 - $3,815
-23 Reduced 1.24%
1,830 $0
Q3 2022

Oct 17, 2022

BUY
$134.21 - $153.93 $3,892 - $4,463
29 Added 1.59%
1,853 $249,000
Q2 2022

Jul 27, 2022

SELL
$137.62 - $174.96 $13,073 - $16,621
-95 Reduced 4.95%
1,824 $279,000
Q1 2022

May 05, 2022

BUY
$131.98 - $163.75 $253,269 - $314,236
1,919 New
1,919 $311,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $296B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Integrity Advisory, LLC Portfolio

Follow Integrity Advisory, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Integrity Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Integrity Advisory, LLC with notifications on news.